SCHEMBL3314937

SCHEMBL3314937

CCN(C(=O)N(C)C)[Si](C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.32
TSHR P16473 1/20 0.30
MLYCD O95822 1/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRM1 P11229 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22680921 0.82 ALDH1A1 (0.31) ALDH1A1TSHR
SCHEMBL9846342 0.80 ALDH1A1 (0.34) ALDH1A1TSHR
SCHEMBL3310787 0.77 ALDH1A1 (0.41) ALDH1A1
SCHEMBL11678374 0.76 CHRM1 (0.38) ALDH1A1CHRM2CHRM4CHRM5CHRM1
SCHEMBL3254074 0.76 LMNA (0.34) ALDH1A1TSHR
SCHEMBL9792595 0.75 ALDH1A1 (0.33) ALDH1A1TSHR
SCHEMBL6672411 0.74 LMNA (0.33) ALDH1A1
SCHEMBL9624015 0.73 DNM1 (0.43) ALDH1A1TSHR
SCHEMBL14674 0.69
SCHEMBL3316208 0.69 ALDH1A1 (0.35) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1318160-B1 Catalysts and process for the preparation of isocyanurate group containing polyisocyanates and their use DEGUSSA (DE) 2007-09-26 EP claimed
EP-1318152-B1 Catalysts and process for preparing polyisocyanates containing isocyanurate groups DEGUSSA (DE) 2007-09-19 EP claimed
US-6875243-B2 Catalysts for preparing polyisocyanates containing isocyanurate groups, and their use DEGUSSA AG (DE) 2005-04-05 US claimed
US-20030135007-A1 Catalysts for preparing polyisocyanates containing isocyanurate groups, and their use DEGUSSA AG (DE) 2003-07-17 US claimed
US-20030109665-A1 Catalysts for preparing polyisocyanates containing isocyanurate groups, and their use DEGUSSA AG (DE) 2003-06-12 US claimed
US-4412073-A Isocyanurate preparation by catalytic, aminosilyl initiated cyclotrimerization of isocyanates RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-10-25 US claimed
US-8445622-B2 Process for preparing polyisocyanates BASF SE (DE) 2013-05-21 US disclosed
US-20100292396-A1 PROCESS FOR PREPARING POLYISOCYANATES BASF SE (DE) 2010-11-18 US disclosed
US-20100105833-A1 WATER-EMULSIFIABLE POLYISOCYANATES BASF SE (DE) 2010-04-29 US disclosed
US-6875243-B2 Catalysts for preparing polyisocyanates containing isocyanurate groups, and their use DEGUSSA AG (DE) 2005-04-05 US disclosed
US-20030135007-A1 Catalysts for preparing polyisocyanates containing isocyanurate groups, and their use DEGUSSA AG (DE) 2003-07-17 US disclosed
US-20030109665-A1 Catalysts for preparing polyisocyanates containing isocyanurate groups, and their use DEGUSSA AG (DE) 2003-06-12 US disclosed
US-4697014-A Catalytic partial cyclotrimerization of polyisocyanates and product thereof RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1987-09-29 US disclosed
US-4675401-A Process for preparing polyisocyanato/polyisocyanurates by catalytic cyclotrimerization of polyisocyanates RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1987-06-23 US disclosed
US-4537961-A Catalytic cyclotrimerization of polyisocyanates RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1985-08-27 US disclosed
US-4412073-A Isocyanurate preparation by catalytic, aminosilyl initiated cyclotrimerization of isocyanates RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1983-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292396-A1 PROCESS FOR PREPARING POLYISOCYANATES PCBP1, ALKBH3, AGPS ALDH1A1 2951/4885TSHR 4847/4885MLYCD 496/4885
US-20100105833-A1 WATER-EMULSIFIABLE POLYISOCYANATES AQP3, AQP1, AQP4 ALDH1A1 2387/4885TSHR 4807/4885MLYCD 1988/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.